TAF6L
Basic information
Region (hg38): 11:62771357-62787342
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TAF6L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 34 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 34 | 1 | 0 |
Variants in TAF6L
This is a list of pathogenic ClinVar variants found in the TAF6L region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-62775884-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
11-62778000-A-T | not specified | Uncertain significance (Sep 30, 2022) | ||
11-62778032-G-A | not specified | Uncertain significance (Oct 27, 2021) | ||
11-62778053-G-C | not specified | Uncertain significance (Aug 12, 2021) | ||
11-62778922-G-A | not specified | Uncertain significance (Feb 13, 2023) | ||
11-62781928-T-C | not specified | Uncertain significance (Aug 10, 2021) | ||
11-62781934-C-T | not specified | Uncertain significance (May 04, 2022) | ||
11-62781939-C-G | not specified | Uncertain significance (Jun 22, 2023) | ||
11-62782180-G-A | not specified | Uncertain significance (Jul 14, 2021) | ||
11-62782183-A-C | not specified | Uncertain significance (Apr 01, 2024) | ||
11-62782213-G-A | not specified | Uncertain significance (Nov 14, 2023) | ||
11-62782270-A-G | not specified | Uncertain significance (Jan 04, 2024) | ||
11-62782321-G-A | not specified | Uncertain significance (May 09, 2023) | ||
11-62782713-G-A | not specified | Uncertain significance (Oct 10, 2023) | ||
11-62782724-C-A | not specified | Uncertain significance (Jan 04, 2022) | ||
11-62782796-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
11-62786623-G-A | not specified | Uncertain significance (May 09, 2023) | ||
11-62786623-G-C | not specified | Uncertain significance (Oct 06, 2022) | ||
11-62786653-G-A | not specified | Uncertain significance (Nov 12, 2021) | ||
11-62786722-C-T | not specified | Uncertain significance (Jun 02, 2024) | ||
11-62786811-G-T | not specified | Uncertain significance (Dec 01, 2022) | ||
11-62786829-C-G | not specified | Uncertain significance (Sep 16, 2021) | ||
11-62786875-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
11-62786922-G-A | not specified | Uncertain significance (Jan 02, 2024) | ||
11-62786922-G-C | not specified | Uncertain significance (Oct 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TAF6L | protein_coding | protein_coding | ENST00000294168 | 10 | 16040 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0701 | 0.930 | 125727 | 0 | 21 | 125748 | 0.0000835 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.846 | 308 | 353 | 0.873 | 0.0000195 | 3903 |
Missense in Polyphen | 60 | 77.558 | 0.77361 | 793 | ||
Synonymous | -0.968 | 171 | 156 | 1.10 | 0.00000849 | 1379 |
Loss of Function | 3.40 | 7 | 25.5 | 0.274 | 0.00000133 | 275 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000233 | 0.000233 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000636 | 0.0000615 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000112 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as a component of the PCAF complex. The PCAF complex is capable of efficiently acetylating histones in a nucleosomal context. The PCAF complex could be considered as the human version of the yeast SAGA complex.;
- Pathway
- Basal transcription factors - Homo sapiens (human);Herpes simplex infection - Homo sapiens (human);Chromatin modifying enzymes;HATs acetylate histones;Chromatin organization
(Consensus)
Recessive Scores
- pRec
- 0.0909
Intolerance Scores
- loftool
- 0.333
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 29.31
Haploinsufficiency Scores
- pHI
- 0.118
- hipred
- Y
- hipred_score
- 0.771
- ghis
- 0.583
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.832
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Taf6l
- Phenotype
Gene ontology
- Biological process
- chromatin organization;chromatin remodeling;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;histone H3 acetylation;positive regulation of nucleic acid-templated transcription
- Cellular component
- histone deacetylase complex;SAGA complex;nucleus;nucleoplasm;transcription factor TFIID complex;STAGA complex;SLIK (SAGA-like) complex;extracellular exosome
- Molecular function
- RNA polymerase II activating transcription factor binding;DNA binding;DNA-binding transcription factor activity;transcription coactivator activity;histone acetyltransferase activity;protein binding;protein heterodimerization activity